| 1000 | 1600369 | Hcas8 | Hepatocarcinoma susceptibility QTL 8 | | | Liver tumor susceptibility | nodule number | 16 | 1 | 24132402 | Rat | n/a | region | qtl |
| 1000 | 631830 | Alc7 | Alcohol consumption QTL 7 | 2.9 | | Consumption level | alcohol preference | 16 | 1 | 26804456 | Rat | n/a | region | qtl |
| 1000 | 634355 | Rends4 | Renal damage susceptibility QTL 4 | | .05 | Renal histology | renal lesion severity | 16 | 1 | 26804456 | Rat | n/a | region | qtl |
| 1000 | 1582235 | Insul8 | Insulin level QTL 8 | 3.3 | .0063 | Insulin level | | 16 | 1 | 26804456 | Rat | n/a | region | qtl |
| 1000 | 2302380 | Slep6 | Serum leptin concentration QTL 6 | 3.36 | | Hormone level | leptin | 16 | 1 | 32464321 | Rat | n/a | region | qtl |
| 1000 | 2307172 | Activ4 | Activity QTL 4 | 3.71 | .00023 | Activity level | Locomotor activity | 16 | 1 | 33735317 | Rat | n/a | region | qtl |
| 1000 | 1354584 | Despr6 | Despair related QTL 6 | | .0067 | Activity level | immobility level | 16 | 1 | 40096603 | Rat | n/a | region | qtl |
| 1000 | 2303566 | Bw90 | Body weight QTL 90 | 2 | | Body weight | | 16 | 1 | 40096603 | Rat | n/a | region | qtl |
| 1000 | 631561 | Hcuc2 | Hepatic copper content QTL 2 | 2.8 | | Copper level | hepatic | 16 | 1 | 40096622 | Rat | n/a | region | qtl |
| 1000 | 6903319 | Bw114 | Body weight QTL 114 | 2.7 | .0037 | Body weight | | 16 | 172013 | 45172013 | Rat | n/a | region | qtl |
| 1000 | 1600378 | Arunc4 | Aerobic running capacity QTL 4 | | .03 | Aerobic running capacity | best distance run to exhaustion | 16 | 350121 | 85734479 | Rat | n/a | region | qtl |
| 1000 | 2293343 | Glom16 | Glomerulus QTL 16 | 9.1 | | Renal pathology | glomerulus inflammation | 16 | 819225 | 49333382 | Rat | n/a | region | qtl |
| 1000 | 2312660 | Bw95 | Body weight QTL 95 | | .05 | Body weight | adiposity index | 16 | 819225 | 63306215 | Rat | n/a | region | qtl |
| 1000 | 2312663 | Slep9 | Serum leptin concentration QTL 9 | | .001 | Hormone level | leptin | 16 | 819225 | 63306215 | Rat | n/a | region | qtl |
| 1000 | 2312666 | Insul16 | Insulin level QTL 16 | | .01 | Insulin level | serum | 16 | 819225 | 63306215 | Rat | n/a | region | qtl |
| 1000 | 2312669 | Stl23 | Serum triglyceride level QTL 23 | | .01 | Lipid level | triglyceride | 16 | 819225 | 63306215 | Rat | n/a | region | qtl |
| 1000 | 1354625 | Despr7 | Despair related QTL 7 | | .016 | Activity level | immobility and climbing levels | 16 | 1632183 | 46632183 | Rat | n/a | region | qtl |
| 1000 | 1300133 | Rf24 | Renal function QTL 24 | 3.64 | | Renal function | salt-loaded creatinine clearance | 16 | 3464719 | 22979073 | Rat | n/a | region | qtl |
| 1000 | 2306902 | Bp339 | Blood pressure QTL 339 | | .01 | Blood pressure | salt-loaded systolic | 16 | 3464719 | 46137590 | Rat | n/a | region | qtl |
| 1000 | 70183 | BpQTLcluster13 | Blood pressure QTL cluster 13 | 3.325 | | Blood pressure | | 16 | 4304396 | 46137590 | Rat | n/a | region | qtl |
| 1000 | 61338 | Bp23 | Blood pressure QTL 23 | 4.3 | | Blood pressure | salt-loaded systolic | 16 | 4304396 | 49304396 | Rat | n/a | region | qtl |
| 1000 | 737819 | Hcas4 | Hepatocarcinoma susceptibility QTL 4 | 4.43 | | Liver tumor susceptibility | nodule number | 16 | 4304396 | 50266190 | Rat | n/a | region | qtl |
| 1000 | 61405 | Niddm6 | Non-insulin dependent diabetes mellitus QTL 6 | 3.66 | .001 | Glucose level | | 16 | 4304396 | 52304351 | Rat | n/a | region | qtl |
| 1000 | 737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | | Consumption level | alcohol preference | 16 | 4304396 | 64081533 | Rat | n/a | region | qtl |
| 1000 | 1357403 | Slep4 | Serum leptin concentration QTL 4 | 3.91 | | Hormone level | leptin | 16 | 9964433 | 30560825 | Rat | n/a | region | qtl |
| 1000 | 631517 | Scl9 | Serum cholesterol level QTL 9 | 3.3 | | Lipid level | cholesterol | 16 | 16194598 | 22671959 | Rat | n/a | region | qtl |
| 1000 | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.2 | | Gastric tumor resistance | tumor invasions depth | 16 | 18121291 | 70196694 | Rat | n/a | region | qtl |
| 1000 | 70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | | Glucose level | postprandial | 16 | 19510772 | 80047126 | Rat | n/a | region | qtl |
| 1000 | 2302057 | Pia29 | Pristane induced arthritis QTL 29 | 3.6 | .001 | Joint/bone inflammation | pristane induced | 16 | 24934312 | 69934312 | Rat | n/a | region | qtl |
| 1000 | 6903294 | Stl30 | Serum triglyceride level QTL 30 | 2.6 | .0013 | Lipid level | triglyceride level | 16 | 28455247 | 73455247 | Rat | n/a | region | qtl |
| 1000 | 1298529 | Arunc1 | Aerobic running capacity QTL 1 | 4 | | Aerobic running capacity | | 16 | 35339929 | 63977788 | Rat | n/a | region | qtl |
| 1000 | 1578768 | Stresp22 | Stress response QTL 22 | 2.8 | | Stress response | thymus weight | 16 | 39026337 | 84026337 | Rat | n/a | region | qtl |
| 1000 | 2293690 | Bss45 | Bone structure and strength QTL 45 | 5.13 | .0001 | Bone structure | | 16 | 41581459 | 86581459 | Rat | n/a | region | qtl |
| 1000 | 2300163 | Bmd64 | Bone mineral density QTL 64 | 5.3 | .0001 | Bone mineral density | | 16 | 41581459 | 86581459 | Rat | n/a | region | qtl |
| 1000 | 631833 | Sach2 | Saccharin preference QTL 2 | 2.5 | .02 | Consumption level | saccharin preference | 16 | 46137355 | 53486191 | Rat | n/a | region | qtl |
| 1000 | 7205510 | Activ5 | Activity QTL 5 | 3.78 | .00028 | Activity level | Locomotor activity | 16 | 46718586 | 90238779 | Rat | n/a | region | qtl |
| 1000 | 631525 | Pia14 | Pristane induced arthritis QTL 14 | 4.4 | | Joint/bone inflammation | arthritis severity | 16 | 59398206 | 88891349 | Rat | n/a | region | qtl |